Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Y Ding

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer|October 25, 2023
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction modelEunji Choi, Sophia J Luo, Victoria Y Ding, et al.
JCO Precision Oncology|April 9, 2026
Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung CancerRika Terashima, Judy Fan, Fatma Gunturkun, et al.
NPJ Digital Medicine|November 29, 2025
Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillanceIngrid Luo, Anna Graber-Naidich, Mengrui Zhang, et al.
Circulation|August 21, 2023
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 TrialFrederik M Zimmermann, Victoria Y Ding, Nico H J Pijls, et al.
Lancet (London, England)|April 2, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trialWilliam F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
The New England Journal of Medicine|November 4, 2021
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass SurgeryWilliam F Fearon, Frederik M Zimmermann, Bernard De Bruyne, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer|October 25, 2023
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction modelEunji Choi, Sophia J Luo, Victoria Y Ding, et al.
JCO Precision Oncology|April 9, 2026
Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung CancerRika Terashima, Judy Fan, Fatma Gunturkun, et al.
NPJ Digital Medicine|November 29, 2025
Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillanceIngrid Luo, Anna Graber-Naidich, Mengrui Zhang, et al.
Circulation|August 21, 2023
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 TrialFrederik M Zimmermann, Victoria Y Ding, Nico H J Pijls, et al.
Lancet (London, England)|April 2, 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trialWilliam F Fearon, Frederik M Zimmermann, Victoria Y Ding, et al.
The New England Journal of Medicine|November 4, 2021
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass SurgeryWilliam F Fearon, Frederik M Zimmermann, Bernard De Bruyne, et al.
Pageof 6